1Quan DJ,Peters MG. Antiviral therapy:nucleotide and nucleoside analogs[J].Clinics in Liver Disease,2004,(02):371-385.doi:10.1016/j.cld.2004.02.012.
2Lok AS,Lai CL,Leung N. Long-term safety of lsmivudine treatment in patients with chronic hepatitis B[J].Gastroenterology,2003,(06):1714-1722.doi:10.1053/j.gastro.2003.09.033.
4Hadziyannis SJ,Tassopoulos NC,Heathcote EJ. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B[J].New England Journal of Medicine,2005,(26):800-807.doi:10.1056/NEJMoa042957.
5Lo CM,Liu CL,Lau GK. Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine[J].Liver Transplantation,2005,(07):807-813.doi:10.1002/lt.20416.
6Perillo R,Hann HW,Mutimer D. Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus[J].Gastroenterology,2004,(01):81-90.doi:10.1053/j.gastro.2003.10.050.
